Kathleen Viola, MD
Dermatology · Sparks Glencoe, MDNPI 1083971436
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Johnson & Johnson accounts for 64.1% of it on its own, with 29 other manufacturers making up the rest. Among dermatology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 829 payments — averaging $47.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$25K
- AbbVie$2K
- Organon$2K
- EPI Health, LLC$2K
- E.r. Squibb & Sons, L.L.C.$1K
- Sanofi$1K
- plus $7K from 24 others
What the payments were for
- Consulting fees$20,30051%
- Travel & lodging$4,13410%
- Food & beverage$14,53937%
- Education$7022%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 208 | $25,438 |
| AbbVie | 89 | $1,722 |
| Organon | 25 | $1,581 |
| EPI Health, LLC | 2 | $1,514 |
| E.r. Squibb & Sons, L.L.C. | 93 | $1,133 |
| Sanofi | 48 | $1,128 |
| Dermavant Sciences, Inc. | 47 | $982 |
| Regeneron Healthcare Solutions, Inc. | 45 | $897 |
| UCB, Inc. | 44 | $729 |
| Sun Pharmaceutical Industries Inc. | 32 | $613 |
| Lilly USA, LLC | 30 | $605 |
| Incyte Corporation | 19 | $456 |
| Novartis | 21 | $412 |
| Pfizer | 19 | $393 |
| Arcutis Biotherapeutics, Inc. | 23 | $363 |
| Galderma Laboratories, L.p. | 24 | $310 |
| LEO Pharma Inc. | 13 | $274 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $245 |
| Amgen | 17 | $242 |
| Regeneron | 1 | $137 |
| Almirall LLC | 5 | $107 |
| Janssen Scientific Affairs, LLC | 1 | $96 |
| Boehringer Ingelheim | 3 | $84 |
| Kyowa Kirin, Inc. | 4 | $73 |
| Botanix SB Inc | 2 | $39 |
| Biofrontera Inc. | 2 | $34 |
| Convatec Inc. | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $23 |
| LNHC, Inc | 1 | $21 |
| Prugen, Inc. Pharmaceuticals | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$39,675 in reported general payments places this provider in the 90th percentile of 306 dermatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $51,670 |
| OpzeluraRuxolitinib Phosphate | 13 | $24,392 |
| Tacrolimus | 33 | $4,835 |
| Clobetasol Propionate | 50 | $3,327 |
| Fluocinonide | 47 | $1,697 |
| Ketoconazole | 94 | $1,373 |
| Metronidazole | 29 | $1,216 |
| Doxycycline Hyclate | 69 | $1,001 |
| Clindamycin Phosphate | 17 | $884 |
| Ammonium Lactate | 32 | $726 |
| Triamcinolone Acetonide | 60 | $724 |
| Nystatin | 50 | $635 |
| Fluconazole | 29 | $275 |
| Mometasone Furoate | 14 | $237 |
| Minoxidil | 22 | $139 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Incyte CorporationOpzelura | $456 | $24,39213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 306 dermatology providers in Maryland.
Other dermatology in Sparks Glencoe
- Deborah EnglertSparks Glencoe$44K
- Benjamin LockshinSilver Spring$4M
- Shawn KwatraBaltimore$1.1M
- Chesahna Kindred WeaverMarriottsville$837K
- Oanh LauringNottingham$763K
- Ronald PrussickN Bethesda$620K
- Rebecca KazinChevy Chase$342K
- Susan WalkerBethesda$221K
- Monte MeltzerBerlin$220K
- Valerie CallenderGlenn Dale$183K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.